Exonics Therapeutics, Inc. — Form D/A
Exonics Therapeutics, Inc. of Watertown, MA, a company, filed a Form D amendment with the SEC on 2018-11-20. The offering totals $42.0M, of which $22.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-11-20
- Form: D/A
- Accession: 0001722820-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $42.0M
- Amount sold: $22.0M
- Remaining: $20.0M
- Investors: 2
- Date of first sale: 2017-11-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-299113
Issuer
- Name: Exonics Therapeutics, Inc.
- CIK: 0001722820
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 490 Arsenal Way, Watertown, MA, 02472
- Phone: 781-749-3987
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| David James Goeddel | Director | Watertown, MA |
| JeenJoo James Kang | Director | Watertown, MA |
| Roger James Perlmutter | Director | Watertown, MA |
| John Ripple | Director | Waltham, MA |
| Jesper James Gromada | Executive Officer | Watertown, MA |
| H. James Magee | Executive Officer | Watertown, MA |
| John Ripple | Executive Officer | Waltham, MA |
Other filings by this issuer (1)
More